Cargando…
STAT3 inhibitors for cancer therapy: Have all roads been explored?
The signal transducer and activator of transcription STAT3 is a transcription factor which plays a key role in normal cell growth and is constitutively activated in about 70% of solid and hematological cancers. Activated STAT3 is phosphorylated on tyrosine and forms a dimer through phosphotyrosine/s...
Autores principales: | Fagard, Remi, Metelev, Valeri, Souissi, Inès, Baran-Marszak, Fanny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670264/ https://www.ncbi.nlm.nih.gov/pubmed/24058788 http://dx.doi.org/10.4161/jkst.22882 |
Ejemplares similares
-
A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line
por: Souissi, Inès, et al.
Publicado: (2012) -
A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB
por: Souissi, Inès, et al.
Publicado: (2011) -
Cellular response to alkylating agent MNNG is impaired in STAT1‐deficients cells
por: Ah‐Koon, Laurent, et al.
Publicado: (2016) -
STAT1 and pathogens, not a friendly relationship
por: Najjar, Imen, et al.
Publicado: (2010) -
Impact of Low-Burden TP53 Mutations in the Management of CLL
por: Lazarian, Gregory, et al.
Publicado: (2022)